Peptide therapy TikTok claims: what the science actually shows

What's this video probably claiming?

Without a transcript, we're working from context here. Creators in the peptide space on TikTok tend to follow predictable playbooks: BPC-157 heals your gut and tendons faster than anything your doctor can prescribe, TB-500 regenerates tissue at a cellular level, and GHK-Cu reverses skin aging while CJC-1295 paired with ipamorelin is basically legal growth hormone. MK-677, which is actually a small molecule secretagogue rather than a true peptide, gets sold as a sleep-improvement and muscle-building compound with none of the downsides of GH therapy. Semax and selank round out the typical stack pitch as nootropics that reduce anxiety and sharpen cognition. These claims aren't random, they reflect real pharmacology. But the gap between what peptides do in a controlled research setting and what a 60-second video implies they'll do for you is substantial.

What does the science actually show?

BPC-157 has genuine mechanistic interest. A 2018 review by Sikiric et al. in Current Pharmaceutical Design documented consistent pro-angiogenic and cytoprotective effects in rat models of colitis, tendon injury, and gastric ulcers. The doses used were typically 10 mcg/kg intraperitoneally. No randomized controlled trial in humans has been published. TB-500, a synthetic fragment of Thymosin Beta-4, showed cardiac repair potential in a Phase II trial (Goldstein et al., 2012, Journal of the American Heart Association), but the effect size was modest and the trial focused on post-infarction patients, not healthy athletes. GHK-Cu does stimulate collagen synthesis in fibroblast cultures, as shown by Finkley et al. (1997, Journal of Peptide Research), but in vitro results don't automatically translate to topical or systemic use in living people. CJC-1295 with ipamorelin does increase pulsatile GH secretion; a 2006 study by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism showed IGF-1 increases of 28-43% over 6 weeks at specific doses.

Where does the social media noise diverge from clinical reality?

The divergence is sharpest on three points. First, species gap: roughly 90% of published BPC-157 and TB-500 research is in rodents. Rat tendons and human tendons are not the same structure, and extrapolating injury recovery timelines from animal models is not science communication, it's speculation dressed as evidence. Second, regulatory status: the FDA placed BPC-157 on the list of bulk drug substances that may not be compounded under 503A or 503B in 2022, citing insufficient clinical evidence. Creators rarely mention this. Third, MK-677 is routinely presented as a safe peptide when it is actually a ghrelin receptor agonist associated with insulin resistance in longer-term use. A 24-month placebo-controlled trial by Nass et al. (2008, Annals of Internal Medicine) found no improvement in functional outcomes in older adults and noted increased fasting glucose. Calling it a muscle-building sleep hack without flagging the metabolic tradeoff is genuinely misleading.

What should you actually know?

Peptides are not inherently dangerous, but the TikTok version of peptide therapy strips out the parts that matter most. Compounded peptides vary significantly in purity, and no regulatory body is routinely testing what's actually in vials sold through wellness clinics or gray-market suppliers. Semax and selank have more human data than most of this category, with Soviet-era clinical work from Russian institutions, though that research doesn't meet modern RCT standards and is nearly impossible to independently verify. If a creator is telling you to stack three or four of these compounds simultaneously, that's not biohacking, it's uncontrolled self-experimentation with substances that have essentially no long-term human safety data. The intellectually honest position: some of these peptides are pharmacologically interesting, a few have early human data worth taking seriously, and none have enough evidence to justify the confident outcome claims that perform well on short-form video.